Citations (136)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Lei Cao, Huicun Zhao, Mengyuan Qian, Chuxiao Shao, Yan Zhang & Jun Yang. (2022) Construction of polysaccharide scaffold-based perfusion bioreactor supporting liver cell aggregates for drug screening. Journal of Biomaterials Science, Polymer Edition 33:17, pages 2249-2269.
Read now
Read now
Maryam Mirahmad, Reyhaneh Sabourian, Mohammad Mahdavi, Bagher Larijani & Maliheh Safavi. (2022) In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation. Drug Metabolism Reviews 54:2, pages 161-193.
Read now
Read now
Han Li, Yu-Guang Wang, Zeng-Chun Ma, Gao Yun-Hang, Song Ling, Chen Teng-Fei, Zhang Guang-Ping & Yue Gao. (2021) A high-throughput cell-based gaussia luciferase reporter assay for measurement of CYP1A1, CYP2B6, and CYP3A4 induction. Xenobiotica 51:7, pages 752-763.
Read now
Read now
Petar D. Petrov, M. Leonor Fernández-Murga, Mireia López-Riera, M. José Goméz-Lechón, Jose V. Castell & Ramiro Jover. (2018) Predicting drug-induced cholestasis: preclinical models. Expert Opinion on Drug Metabolism & Toxicology 14:7, pages 721-738.
Read now
Read now
Otto Kučera, René Endlicher, David Rychtrmoc, Halka Lotková, Ondřej Sobotka & Zuzana Červinková. (2017) Acetaminophen toxicity in rat and mouse hepatocytes in vitro. Drug and Chemical Toxicology 40:4, pages 448-456.
Read now
Read now
Richard J. Weaver, Catherine Betts, Eric A.G. Blomme, Helga H.J. Gerets, Klaus Gjervig Jensen, Philip G. Hewitt, Satu Juhila, Gilles Labbe, Michael J. Liguori, Natalie Mesens, Monday O. Ogese, Mikael Persson, Jan Snoeys, James L. Stevens, Tracy Walker & B. Kevin Park. (2017) Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 13:7, pages 767-782.
Read now
Read now
Maria Teresa Donato, Maria José Gómez-Lechón & Laia Tolosa. (2017) Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies. Expert Opinion on Drug Discovery 12:2, pages 201-211.
Read now
Read now
M. José Gómez-Lechón, Laia Tolosa & M. Teresa Donato. (2017) Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing. Expert Opinion on Drug Metabolism & Toxicology 13:2, pages 137-148.
Read now
Read now
Articles from other publishers (128)
Yiling Ge, Sheng Yang, Tianyi Zhang, Xin Wan, Yuxin Zhu, Fei Yang, Lihong Yin, Yuepu Pu & Geyu Liang. (2023) The hepatotoxicity assessment of micro/nanoplastics: A preliminary study to apply the adverse outcome pathways. Science of The Total Environment 902, pages 165659.
Crossref
Crossref
Faiza Farhan, Manjari Trivedi, Priscilla Di Wu & Wei Cui. (2023) Extracellular matrix modulates the spatial hepatic features in hepatocyte-like cells derived from human embryonic stem cells. Stem Cell Research & Therapy 14:1.
Crossref
Crossref
Eva Sanchez-Quant, Maria Lucia Richter, Maria Colomé-Tatché & Celia Pilar Martinez-Jimenez. (2023) Single-cell metabolic profiling reveals subgroups of primary human hepatocytes with heterogeneous responses to drug challenge. Genome Biology 24:1.
Crossref
Crossref
Julio Rodriguez-Fernandez, Emma Garcia-Legler, Estela Villanueva-Badenas, M. Teresa Donato, José Luis Gomez-Ribelles, Manuel Salmeron-Sanchez, Gloria Gallego-Ferrer & Laia Tolosa. (2023) Primary human hepatocytes-laden scaffolds for the treatment of acute liver failure. Biomaterials Advances 153, pages 213576.
Crossref
Crossref
V. N. Perfilova. (2023) Opportunities and Prospects for Preclinical Drug Safety Assessment Using Alternative Methods: Experience from the Toxicology in the 21st Century (Tox21) Programme in the USA. Safety and Risk of Pharmacotherapy.
Crossref
Crossref
Kristin Beirow, Christian Schmidt, Britta Jürgen, Rabea Schlüter, Thomas Schweder & Patrick J. Bednarski. (2023)
Investigation of TGF‐
α
‐overexpressing mouse hepatocytes (TAMH) cultured as spheroids for use in hepatotoxicity screening of drug candidates
. Journal of Applied Toxicology.
Crossref
Crossref
Tara J. Bowen, Andrew D. Southam, Andrew R. Hall, Ralf J. M. Weber, Gavin R. Lloyd, Ruth Macdonald, Amanda Wilson, Amy Pointon & Mark R. Viant. (2023) Simultaneously discovering the fate and biochemical effects of pharmaceuticals through untargeted metabolomics. Nature Communications 14:1.
Crossref
Crossref
Limei Li, Qingce Zang, Xinzhu Li, Ying Zhu, Shanjing Wen, Jiuming He, Ruiping Zhang & Zeper Abliz. (2023) Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids. Journal of Pharmaceutical Analysis 13:5, pages 483-493.
Crossref
Crossref
Jingyu Fu, Hailong Qiu & Cherie S. Tan. (2023) Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery. Pharmaceutics 15:4, pages 1300.
Crossref
Crossref
Shu Yang, Masato Ooka, Ryan Jared Margolis & Menghang Xia. (2023) Liver three-dimensional cellular models for high-throughput chemical testing. Cell Reports Methods 3:3, pages 100432.
Crossref
Crossref
Y.-H. Chen, Y.-T. Shih, C.-S. Chien & C.-S. Tsai. (2022) Predicting adverse drug effects: A heterogeneous graph convolution network with a multi-layer perceptron approach. PLOS ONE 17:12, pages e0266435.
Crossref
Crossref
Lulu Zhao, Hongying Cai, Yongbao Wu, Changfu Tian, Zhiguo Wen & Peilong Yang. (2022) Severe choline deficiency induces alternative splicing aberrance in optimized duck primary hepatocyte cultures. Animal Bioscience 35:11, pages 1787-1799.
Crossref
Crossref
M. Teresa Donato, Gloria Gallego-Ferrer & Laia Tolosa. (2022) In Vitro Models for Studying Chronic Drug-Induced Liver Injury. International Journal of Molecular Sciences 23:19, pages 11428.
Crossref
Crossref
Taha Messelmani, Anne Le Goff, Zied Souguir, Victoria Maes, Méryl Roudaut, Elodie Vandenhaute, Nathalie Maubon, Cécile Legallais, Eric Leclerc & Rachid Jellali. (2022) Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix. Bioengineering 9:9, pages 443.
Crossref
Crossref
Philip Dalsbecker, Caroline Beck Adiels & Mattias Goksör. (2022) Liver-on-a-chip devices: the pros and cons of complexity. American Journal of Physiology-Gastrointestinal and Liver Physiology 323:3, pages G188-G204.
Crossref
Crossref
Valon Llabjani, M. R. Siddique, Anaïs Macos, Afaf Abouzid, Valmira Hoti, Francis L. Martin, Imran I. Patel & Ahtasham Raza. (2022) Introducing CELLBLOKS®: a novel organ-on-a-chip platform allowing a plug-and-play approach towards building organotypic models. In vitro models 1:6, pages 423-435.
Crossref
Crossref
Taha Messelmani, Lisa Morisseau, Yasuyuki Sakai, Cécile Legallais, Anne Le Goff, Eric Leclerc & Rachid Jellali. (2022) Liver organ-on-chip models for toxicity studies and risk assessment. Lab on a Chip 22:13, pages 2423-2450.
Crossref
Crossref
Xueming Niu, Mian Lin & Bae Hoon Lee. (2022) An Engineered Protein-Based Building Block (Albumin Methacryloyl) for Fabrication of a 3D In Vitro Cryogel Model. Gels 8:7, pages 404.
Crossref
Crossref
Patrick Mai, Jörg Hampl, Martin Baca, Dana Brauer, Sukhdeep Singh, Frank Weise, Justyna Borowiec, André Schmidt, Johanna Merle Küstner, Maren Klett, Michael Gebinoga, Insa S. Schroeder, Udo R. Markert, Felix Glahn, Berit Schumann, Diana Eckstein & Andreas Schober. (2022) MatriGrid® Based Biological Morphologies: Tools for 3D Cell Culturing. Bioengineering 9:5, pages 220.
Crossref
Crossref
Dganit Stern-Tal, Shmulik Ittah & Ella Sklan. (2021) A new cell-sized support for 3D cell cultures based on recombinant spider silk fibers. Journal of Biomaterials Applications 36:10, pages 1748-1757.
Crossref
Crossref
Marta Moreno-Torres, Manoj Kumar, Guillem García-Llorens, Guillermo Quintás, Tine Tricot, Ruben Boon, Laia Tolosa, Burak Toprakhisar, Francois ChesnaisCatherine Verfaillie & José V. Castell. (2022) A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes. Journal of Proteome Research 21:3, pages 702-712.
Crossref
Crossref
Yasuyuki Naito, Yuka Yoshinouchi, Yukiko Sorayama, Hiroshi Kohara, Shiro Kitano, Shinji Irie & Michiya Matsusaki. (2022) Constructing vascularized hepatic tissue by cell-assembled viscous tissue sedimentation method and its application for vascular toxicity assessment. Acta Biomaterialia 140, pages 275-288.
Crossref
Crossref
Shyama Sasikumar, Shibu Chameettachal, Peter Kingshott, Brett Cromer & Falguni Pati. (2022) Influence of Liver Extracellular Matrix in Predicting Drug-Induced Liver Injury: An Alternate Paradigm. ACS Biomaterials Science & Engineering 8:2, pages 834-846.
Crossref
Crossref
Frances Widjaja, Yasser Alhejji & Ivonne M. C. M. Rietjens. (2021) The Role of Kinetics as Key Determinant in Toxicity of Pyrrolizidine Alkaloids and Their N-Oxides. Planta Medica 88:02, pages 130-143.
Crossref
Crossref
Xiaoying Ma, Jiadi Sun, Yongli Ye, Jian Ji & Xiulan Sun. (2022) Application of triple co-cultured cell spheroid model for exploring hepatotoxicity and metabolic pathway of AFB1. Science of The Total Environment 807, pages 150840.
Crossref
Crossref
Sonia Youhanna, Aurino M. Kemas, Lena Preiss, Yitian Zhou, Joanne X. Shen, Selgin D. Cakal, Francesco S. Paqualini, Sravan K. Goparaju, Reza Zandi Shafagh, Johan Ulrik Lind, Carl M. Sellgren & Volker M. Lauschke. (2022) Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives. Pharmacological Reviews 74:1, pages 141-206.
Crossref
Crossref
Christopher Hadjittofi, Michael Feretis, Jack Martin, Simon Harper & Emmanuel Huguet. (2021) Liver regeneration biology: Implications for liver tumour therapies. World Journal of Clinical Oncology 12:12, pages 1101-1156.
Crossref
Crossref
Sreya Ghosh, Jonathan De Smedt, Tine Tricot, Susana Proença, Manoj Kumar, Fatemeharefeh Nami, Thomas Vanwelden, Niels Vidal, Paul Jennings, Nynke I. Kramer & Catherine M. Verfaillie. (2021) HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity. Toxics 10:1, pages 1.
Crossref
Crossref
Antonio Segovia-Zafra, Daniel E. Di Zeo-Sánchez, Carlos López-Gómez, Zeus Pérez-Valdés, Eduardo García-Fuentes, Raúl J. Andrade, M. Isabel Lucena & Marina Villanueva-Paz. (2021) Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharmaceutica Sinica B 11:12, pages 3685-3726.
Crossref
Crossref
Siming Lu, Jingwei Zhang, Sha Lin, Danfeng Zheng, Yan Shen, Jiale Qin, Yangyang Li & Shuqi Wang. (2021) Recent advances in the development of in vitro liver models for hepatotoxicity testing. Bio-Design and Manufacturing 4:4, pages 717-734.
Crossref
Crossref
Manon C. Bouwmeester, Paulina N. Bernal, Loes A. Oosterhoff, Monique E. van Wolferen, Vivian Lehmann, Monique Vermaas, Maj‐Britt Buchholz, Quentin C. Peiffer, Jos Malda, Luc J. W. van der Laan, Nynke I. Kramer, Kerstin Schneeberger, Riccardo Levato & Bart Spee. (2021) Bioprinting of Human Liver‐Derived Epithelial Organoids for Toxicity Studies. Macromolecular Bioscience 21:12.
Crossref
Crossref
Toshikatsu Matsui & Tadahiro Shinozawa. (2021) Human Organoids for Predictive Toxicology Research and Drug Development. Frontiers in Genetics 12.
Crossref
Crossref
Niklas Handin, Evgeniya Mickols, Magnus Ölander, Jakob Rudfeldt, Kristin Blom, Frida Nyberg, Wojciech Senkowski, Jozef Urdzik, Varun Maturi, Mårten Fryknäs & Per Artursson. (2021) Conditions for maintenance of hepatocyte differentiation and function in 3D cultures. iScience 24:11, pages 103235.
Crossref
Crossref
Qianqian Xu. (2021) Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Michela Anna Polidoro, Erika Ferrari, Simona Marzorati, Ana Lleo & Marco Rasponi. (2021) Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip. Liver International 41:8, pages 1744-1761.
Crossref
Crossref
Shida Qiao, Sisi Feng, Zhitao Wu, Ting He, Chen Ma, Zhaoliang Peng, E. Tian & Guoyu Pan. (2021) Functional Proliferating Human Hepatocytes: In Vitro Hepatocyte Model for Drug Metabolism, Excretion, and Toxicity. Drug Metabolism and Disposition 49:4, pages 305-313.
Crossref
Crossref
Xi Chen, Yu Shrike Zhang, Xinping Zhang & Changsheng Liu. (2021) Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine. Bioactive Materials 6:4, pages 1012-1027.
Crossref
Crossref
Yixiang Zhong, Jun Sang Yu, Xiaoqiong Wang, Bert Binas & Hye Hyun Yoo. (2021) Chemical‐based primary human hepatocyte monolayer culture for the study of drug metabolism and hepatotoxicity: Comparison with the spheroid model. The FASEB Journal 35:3.
Crossref
Crossref
Keri Dame & Alexandre JS Ribeiro. (2020) Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects. Experimental Biology and Medicine 246:3, pages 317-331.
Crossref
Crossref
Meixian Jin, Xiao Yi, Wei Liao, Qi Chen, Wanren Yang, Yang Li, Shao Li, Yi Gao, Qing Peng & Shuqin Zhou. (2021) Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
María Teresa Donato & Laia Tolosa. (2021) High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells. Antioxidants 10:1, pages 106.
Crossref
Crossref
M. Teresa Donato & Laia Tolosa. (2021) Application of high-content screening for the study of hepatotoxicity: Focus on food toxicology. Food and Chemical Toxicology 147, pages 111872.
Crossref
Crossref
M. Teresa Donato, María Pelechá & Laia Tolosa. 2021. Recent Advances in iPSCs for Therapy, Volume 3. Recent Advances in iPSCs for Therapy, Volume 3
225
250
.
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal & Ankur Vaidya. 2021. Nanotechnology Applications for Cancer Chemotherapy. Nanotechnology Applications for Cancer Chemotherapy
599
609
.
Eckhard von Keutz. 2020. Regulatory Toxicology. Regulatory Toxicology
1
10
.
Eckhard von Keutz. 2021. Regulatory Toxicology. Regulatory Toxicology
139
148
.
Aneesha Basharat, Helen E. Rollison, Dominic P. Williams & Delyan P. Ivanov. (2020) HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI). Toxicology and Applied Pharmacology 408, pages 115279.
Crossref
Crossref
Linhao Li, Hongbing Wang & Jace W. Jones. (2020) Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury. Prostaglandins & Other Lipid Mediators 151, pages 106484.
Crossref
Crossref
Erin Milner, Michael Ainsworth, Matthew McDonough, Benjamin Stevens, Johannah Buehrer, Richard Delzell, Cameron Wilson & Jason Barnhill. (2020) Emerging Three-Dimensional Hepatic Models in Relation to Traditional Two-Dimensional In Vitro Assays for Evaluating Drug Metabolism and Hepatoxicity. Medicine in Drug Discovery 8, pages 100060.
Crossref
Crossref
Christopher R. Cox, Stephen Lynch, Christopher Goldring & Parveen Sharma. (2020) Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury. Frontiers in Medical Technology 2.
Crossref
Crossref
Zhengyi Jiang, Zeyu Sun, Xiaoxi Ouyang, Yalei Zhao, Menghao Zhou, Baohong Wang, Qirui Li, Linxiao Fan, Sainan Zhang & Lanjuan Li. (2020) Temporal Integrative Omics Reveals an Increase in Nondegradative Ubiquitylation during Primary Hepatocyte Dedifferentiation. Engineering 6:11, pages 1302-1314.
Crossref
Crossref
B Lucendo-Villarin, J Meseguer-Ripolles, J Drew, L Fischer, E Ma, O Flint, K J Simpson, L M Machesky, J C Mountford & D C Hay. (2020) Development of a cost-effective automated platform to produce human liver spheroids for basic and applied research. Biofabrication 13:1, pages 015009.
Crossref
Crossref
Roni F. Kunst, Marije Niemeijer, Luc J.W. van der Laan, Bart Spee & Stan F.J. van de Graaf. (2020) From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease. Biochemical Pharmacology 180, pages 114173.
Crossref
Crossref
Veronica Zingales, Clarissa Fedeli, Mónica Fernández-Franzón & Maria-José Ruiz. (2020) Cytotoxic effects of individual and combined sterigmatocystin and nivalenol on liver hepatocellular carcinoma cells. Food and Chemical Toxicology 143, pages 111473.
Crossref
Crossref
Faezah Hussain, Sreetama Basu, Javen Jun Hao Heng, Lit-Hsin Loo & Daniele Zink. (2020) Predicting direct hepatocyte toxicity in humans by combining high-throughput imaging of HepaRG cells and machine learning-based phenotypic profiling. Archives of Toxicology 94:8, pages 2749-2767.
Crossref
Crossref
Ramona Nudischer, Kasper Renggli, Andreas Hierlemann, Adrian B. Roth & Cristina Bertinetti-Lapatki. (2020) Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity. PLOS ONE 15:7, pages e0235745.
Crossref
Crossref
Feng Li, Li Cao, Sweta Parikh & Rongjun Zuo. (2020) Three-Dimensional Spheroids With Primary Human Liver Cells and Differential Roles of Kupffer Cells in Drug-Induced Liver Injury. Journal of Pharmaceutical Sciences 109:6, pages 1912-1923.
Crossref
Crossref
Daniele Zink, Jacqueline Kai Chin Chuah & Jackie Y. Ying. (2020) Assessing Toxicity with Human Cell-Based In Vitro Methods. Trends in Molecular Medicine 26:6, pages 570-582.
Crossref
Crossref
Farah Tasnim, Nisha Hari Singh, Elijah Keng Foo Tan, Jiangwa Xing, Huan Li, Sebastien Hissette, Sravanthy Manesh, Justina Fulwood, Kapish Gupta, Chan Way Ng, Shuoyu Xu, Jeffrey Hill & Hanry Yu. (2020) Tethered primary hepatocyte spheroids on polystyrene multi-well plates for high-throughput drug safety testing. Scientific Reports 10:1.
Crossref
Crossref
Ruben Boon, Manoj Kumar, Tine Tricot, Ilaria Elia, Laura Ordovas, Frank Jacobs, Jennifer One, Jonathan De Smedt, Guy Eelen, Matthew Bird, Philip Roelandt, Ginevra Doglioni, Kim Vriens, Matteo Rossi, Marta Aguirre Vazquez, Thomas Vanwelden, François Chesnais, Adil El Taghdouini, Mustapha Najimi, Etienne Sokal, David Cassiman, Jan Snoeys, Mario Monshouwer, Wei-Shou Hu, Christian Lange, Peter Carmeliet, Sarah-Maria Fendt & Catherine M. Verfaillie. (2020) Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines. Nature Communications 11:1.
Crossref
Crossref
Jeong Seong Kim, Seon In Hwang, Jung Lim Ryu, Hee Su Hong, Ji-Min Lee, Sang Min Lee, Xiong Jin, Choongseong Han, Jong-Hoon Kim, Jaeseok Han, Man-Ryul Lee & Dong-Hun Woo. (2020) ER stress reliever enhances functionalities of in vitro cultured hepatocytes. Stem Cell Research 43, pages 101732.
Crossref
Crossref
Jorke Willemse, Monique M.A. Verstegen, Annewiet Vermeulen, Ivo J. Schurink, Henk P. Roest, Luc J.W. van der Laan & Jeroen de Jonge. (2020) Fast, robust and effective decellularization of whole human livers using mild detergents and pressure controlled perfusion. Materials Science and Engineering: C 108, pages 110200.
Crossref
Crossref
Rachid Jellali, Myriam Lereau Bernier, Yannick Tauran, Françoise Gilard, Mathieu Danoy, Taketomo Kido, Atsushi Miyajima, Yasuyuki Sakai & Eric Leclerc. (2020) Metabolomic profiling during the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. Differentiation 112, pages 17-26.
Crossref
Crossref
Lauren R. Wills & Padmavathy Rajagopalan. (2019) Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing. Annals of Biomedical Engineering 48:3, pages 1045-1057.
Crossref
Crossref
Jan G. Hengstler, Anna-Karin Sjögren, Daniele Zink & Jorrit J. Hornberg. (2020) In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity. Archives of Toxicology 94:2, pages 353-356.
Crossref
Crossref
Konrad Schmidt, Johanna Berg, Viola Roehrs, Jens Kurreck & Munir A. Al-Zeer. (2020) 3D-bioprinted HepaRG cultures as a model for testing long term aflatoxin B1 toxicity in vitro. Toxicology Reports 7, pages 1578-1587.
Crossref
Crossref
Dagmara Szkolnicka & David C. Hay. 2020. Principles of Tissue Engineering. Principles of Tissue Engineering
723
736
.
Jinpeng LiRaja S. SettivariMatthew J. LeBaronMary Sue Marty. (2019) Functional Comparison of HepaRG Cells and Primary Human Hepatocytes in Sandwich and Spheroid Culture as Repeated-Exposure Models for Hepatotoxicity. Applied In Vitro Toxicology 5:4, pages 187-195.
Crossref
Crossref
Yitian Zhou, Joanne X. Shen & Volker M. Lauschke. (2019) Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury. Frontiers in Pharmacology 10.
Crossref
Crossref
Miroslav Mišík, Armen Nersesyan, Nathalie Ropek, Wolfgang W. Huber, Elisabeth Haslinger & Siegfried Knasmueller. (2019) Use of human derived liver cells for the detection of genotoxins in comet assays. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 845, pages 402995.
Crossref
Crossref
Jia Ning, Lu Chen & Ivonne M.C.M. Rietjens. (2019) Role of toxicokinetics and alternative testing strategies in pyrrolizidine alkaloid toxicity and risk assessment; state-of-the-art and future perspectives. Food and Chemical Toxicology 131, pages 110572.
Crossref
Crossref
Zhen-Yu Wang, Wei-Jian Li, Qi-Gen Li, Hong-Shu Jing, Tian-Jie Yuan, Gong-Bo Fu, Dan Tang, Hong-Dan Zhang, He-Xin Yan & Bo Zhai. (2019) A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro. Biomedicine & Pharmacotherapy 116, pages 109010.
Crossref
Crossref
Michael D. Aleo, Okechukwu Ukairo, Amanda Moore, Onyi Irrechukwu, David M. Potter & Richard P. Schneider. (2019)
Liver safety evaluation of endothelin receptor antagonists using HepatoPac
®
: A single model impact assessment on hepatocellular health, function and bile acid disposition
. Journal of Applied Toxicology 39:8, pages 1192-1207.
Crossref
Crossref
Anders Bork Davidsen, Marie Mardal & Kristian Linnet. (2019) In Vitro Metabolism and Hepatic Intrinsic Clearance of the Synthetic Cannabinoid Receptor Agonist JWH-122 and Its Four ω-Halogenated Analogues. The AAPS Journal 21:4.
Crossref
Crossref
So Yoon Yun, Ju Yeun Kim, Moon Jung Back, Hee Soo Kim, Hae Chan Ha, Ji Min Jang & Dae Kyong Kim. (2019) Comparison of three human liver cell lines for in vitro drug-induced liver injury assessment: Huh7, HepaRG, and stem cell-derived hepatocytes. Molecular & Cellular Toxicology 15:3, pages 271-285.
Crossref
Crossref
Lingyan Wu, Gaia Ferracci, Yan Wang, Teng Fei Fan, Nam-Joon Cho & Pierce K. H. Chow. (2019)
Porcine hepatocytes culture on biofunctionalized 3D inverted colloidal crystal scaffolds as an
in vitro
model for predicting drug hepatotoxicity
. RSC Advances 9:31, pages 17995-18007.
Crossref
Crossref
Chengang Xiang, Yuanyuan Du, Gaofan Meng, Liew Soon Yi, Shicheng Sun, Nan Song, Xiaonan Zhang, Yiwei Xiao, Jie Wang, Zhigang Yi, Yifang Liu, Bingqing Xie, Min Wu, Jun Shu, Da Sun, Jun Jia, Zhen Liang, Dong Sun, Yanxiang Huang, Yan Shi, Jun Xu, Fengmin Lu, Cheng Li, Kuanhui Xiang, Zhenghong Yuan, Shichun Lu & Hongkui Deng. (2019) Long-term functional maintenance of primary human hepatocytes in vitro. Science 364:6438, pages 399-402.
Crossref
Crossref
Jonathan A. Kyffin, Parveen Sharma, Joseph Leedale, Helen E. Colley, Craig Murdoch, Amy L. Harding, Pratibha Mistry & Steven D. Webb. (2019) Characterisation of a functional rat hepatocyte spheroid model. Toxicology in Vitro 55, pages 160-172.
Crossref
Crossref
M. Teresa Donato & Laia Tolosa. (2019) Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury. Differentiation 106, pages 15-22.
Crossref
Crossref
Laia Tolosa, Nuria Jiménez, María Pelechá, José V. Castell, Mª José Gómez-Lechón & M. Teresa Donato. (2018) Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes. Archives of Toxicology 93:2, pages 519-532.
Crossref
Crossref
Pilar Sainz-Arnal, Iris Pla-Palacín, Natalia Sánchez-Romero, Manuel Almeida, Sara Morini, Estela Solanas, Alberto Lue, Trinidad Serrano-Aulló & Pedro M. Baptista. 2019. Principles of Regenerative Medicine. Principles of Regenerative Medicine
1101
1113
.
Stefanie BueschJenny SchroederMaureen BungerTheresa D'SouzaMagdalene Stosik. (2018)
A Novel
In Vitro
Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies
. Applied In Vitro Toxicology 4:3, pages 232-237.
Crossref
Crossref
Alexander J. Kvist, Kajsa P. Kanebratt, Anna Walentinsson, Henrik Palmgren, Matthew O'Hara, Anders Björkbom, Linda C. Andersson, Marie Ahlqvist & Tommy B. Andersson. (2018) Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines. Biochemical Pharmacology 155, pages 124-140.
Crossref
Crossref
Yuri L. Boteon, Lorraine Wallace, Amanda P. C. S. Boteon, Darius F. Mirza, Hynek Mergental, Ricky H. Bhogal & Simon Afford. (2018) An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells. PLOS ONE 13:7, pages e0201419.
Crossref
Crossref
Sabine U Vorrink, Yitian Zhou, Magnus Ingelman-Sundberg & Volker M Lauschke. (2018) Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions. Toxicological Sciences 163:2, pages 655-665.
Crossref
Crossref
Lihan Sun, Huajing Wu, Lianjie Ren, Jiaojiao Cong, Xiaohui Qin, Xingli Wang, Xinming Qi, Lifeng Kang, Junying Zhang & Chunyong Wu. (2018) Development and validation of a highly sensitive LC-MS/MS method for determination of brain active agent dianhydrogalactitol in mouse plasma and tissues: Application to a pharmacokinetic study. Journal of Chromatography B 1087-1088, pages 90-97.
Crossref
Crossref
Catherine C Bell, Anita C A Dankers, Volker M Lauschke, Rowena Sison-Young, Roz Jenkins, Cliff Rowe, Chris E Goldring, Kevin Park, Sophie L Regan, Tracy Walker, Chris Schofield, Audrey Baze, Alison J Foster, Dominic P Williams, Amy W M van de Ven, Frank Jacobs, Jos van Houdt, Tuula Lähteenmäki, Jan Snoeys, Satu Juhila, Lysiane Richert & Magnus Ingelman-Sundberg. (2018) Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study. Toxicological Sciences 162:2, pages 655-666.
Crossref
Crossref
Jonathan A. Kyffin, Parveen Sharma, Joseph Leedale, Helen E. Colley, Craig Murdoch, Pratibha Mistry & Steven D. Webb. (2018) Impact of cell types and culture methods on the functionality of in vitro liver systems – A review of cell systems for hepatotoxicity assessment. Toxicology in Vitro 48, pages 262-275.
Crossref
Crossref
Li Li, Bing Chen, Hongbin Yan, Yannan Zhao, Zhongzi Lou, Jianqiu Li, Baoquan Fu, Xingquan Zhu, Donald P. McManus, Jianwu Dai & Wanzhong Jia. (2018) Three-dimensional hepatocyte culture system for the study of Echinococcus multilocularis larval development. PLOS Neglected Tropical Diseases 12:3, pages e0006309.
Crossref
Crossref
Eliza Li Shan Fong, Tan Boon Toh, Quy Xiao Xuan Lin, Zheng Liu, Lissa Hooi, Masturah Bte Mohd Abdul Rashid, Touati Benoukraf, Edward Kai-Hua Chow, The Hung Huynh & Hanry Yu. (2018) Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer. Biomaterials 159, pages 229-240.
Crossref
Crossref
Lorna EwartEva-Maria Dehne, Kristin Fabre, Susan Gibbs, James Hickman, Ellinor Hornberg, Magnus Ingelman-Sundberg, Kyung-Jin Jang, David R. Jones, Volker M. Lauschke, Uwe Marx, Jerome T. Mettetal, Amy PointonDominic WilliamsWolfram-Hubertus Zimmermann & Peter Newham. (2018) Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery. Annual Review of Pharmacology and Toxicology 58:1, pages 65-82.
Crossref
Crossref
Jose Meseguer-Ripolles, Salman R. Khetani, Javier G. Blanco, Mairi Iredale & David C. Hay. (2017) Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety. The AAPS Journal 20:1.
Crossref
Crossref
Laia Tolosa, Nuria Jiménez, Gabriela Pérez, José V. Castell, M. José Gómez-Lechón & M. Teresa Donato. (2017) Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury. Archives of Toxicology 92:1, pages 383-399.
Crossref
Crossref
Matthew Brovold, Joana I. Almeida, Iris Pla-Palacín, Pilar Sainz-Arnal, Natalia Sánchez-Romero, Jesus J. Rivas, Helen Almeida, Pablo Royo Dachary, Trinidad Serrano-Aulló, Shay Soker & Pedro M. Baptista. 2018. Novel Biomaterials for Regenerative Medicine. Novel Biomaterials for Regenerative Medicine
421
449
.
Estela Solanas, Iris Pla-Palacín, Pilar Sainz-Arnal, Manuel Almeida, Alberto Lue, Trinidad Serrano & Pedro M. Baptista. 2018. Tumor Organoids. Tumor Organoids
17
33
.
Lit-Hsin Loo & Daniele Zink. (2017) High-throughput Prediction of Nephrotoxicity in Humans. Alternatives to Laboratory Animals 45:5, pages 241-252.
Crossref
Crossref
Banya Yi, Kyu Young Shim, Sang Keun Ha, Jeonghun Han, Hong-Hoa Hoang, Inwook Choi, Sungsu Park & Jong Hwan Sung. (2017) Three-dimensional in vitro gut model on a villi-shaped collagen scaffold. BioChip Journal 11:3, pages 219-231.
Crossref
Crossref
Ramy Elgendy, Mery Giantin & Mauro Dacasto. (2017) Transcriptomic characterization of bovine primary cultured hepatocytes; a cross-comparison with a bovine liver and the Madin-Darby bovine kidney cells. Research in Veterinary Science 113, pages 40-49.
Crossref
Crossref
Sabine U. Vorrink, Shahid Ullah, Staffan Schmidt, Jatin Nandania, Vidya Velagapudi, Olof Beck, Magnus Ingelman‐Sundberg & Volker M. Lauschke. (2017) Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long‐term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics. The FASEB Journal 31:6, pages 2696-2708.
Crossref
Crossref
Wendy J. Bailey & Warren Glaab. (2017) Derisking drug-induced liver injury from bench to bedside. Current Opinion in Toxicology 4, pages 52-58.
Crossref
Crossref
M. Cipriano, J. C. Correia, S. P. Camões, N. G. Oliveira, P. Cruz, H. Cruz, M. Castro, J. L. Ruas, J. M. Santos & J. P. Miranda. (2016) The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells. Archives of Toxicology 91:6, pages 2469-2489.
Crossref
Crossref
Catherine C. Bell, Volker M. Lauschke, Sabine U. Vorrink, Henrik Palmgren, Rodger Duffin, Tommy B. Andersson & Magnus Ingelman-Sundberg. (2017) Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell–Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury. Drug Metabolism and Disposition 45:4, pages 419-429.
Crossref
Crossref
Danielle Marquete Vitelli-Avelar, Renato Sathler-Avelar, Armanda Moreira Mattoso-Barbosa, Nicolas Gouin, Marcelo Perdigão-de-Oliveira, Leydiane Valério-dos-Reis, Ronaldo Peres Costa, Silvana Maria Elói-Santos, Matheus de Souza Gomes, Laurence Rodrigues do Amaral, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, Edward J. Dick, Gene B. Hubbard, Jane F. VandeBerg & John L. VandeBerg. (2017) Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease. PLOS Neglected Tropical Diseases 11:2, pages e0005233.
Crossref
Crossref
Daniel Moreno, Leire Neri, Eva Vicente, Africa Vales & Rafael Aldabe. 2017. Hepatocyte Transplantation. Hepatocyte Transplantation
179
192
.
Volker M. Lauschke, Delilah F. G. Hendriks, Catherine C. Bell, Tommy B. Andersson & Magnus Ingelman-Sundberg. (2016) Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates. Chemical Research in Toxicology 29:12, pages 1936-1955.
Crossref
Crossref
Alexander Gosslau. 2016. Food Toxicology. Food Toxicology
11
34
.
Volker Lauschke & Magnus Ingelman-Sundberg. (2016) The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity. International Journal of Molecular Sciences 17:10, pages 1714.
Crossref
Crossref
Gordon J. Dear & Angus N. R. Nedderman. 2016. Metabolite Safety in Drug Development. Metabolite Safety in Drug Development
17
43
.
Alexander Gosslau. (2016) Assessment of food toxicology. Food Science and Human Wellness 5:3, pages 103-115.
Crossref
Crossref
María José Gómez-Lechón & Laia Tolosa. (2016) Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening. Archives of Toxicology 90:9, pages 2049-2061.
Crossref
Crossref
Laia Tolosa, M. Jos? G?mez-Lech?n, Silvia L?pez, Carla Guzm?n, Jos? V. Castell, M. Teresa Donato & Ramiro Jover. (2016) Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing. Toxicological Sciences 152:1, pages 214-229.
Crossref
Crossref
Zara Hannoun, Clara Steichen, Noushin Dianat, Anne Weber & Anne Dubart-Kupperschmitt. (2016) The potential of induced pluripotent stem cell derived hepatocytes. Journal of Hepatology 65:1, pages 182-199.
Crossref
Crossref
Alexander V. LyubimovCarolina Garcia‐Canton & Emmanuel Minet. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
31
.
M. José Gómez-Lechón, Laia Tolosa & M. Teresa Donato. (2016)
Metabolic activation and drug-induced liver injury:
in vitro
approaches for the safety risk assessment of new drugs
. Journal of Applied Toxicology 36:6, pages 752-768.
Crossref
Crossref
Catherine C. Bell, Delilah F. G. Hendriks, Sabrina M. L. Moro, Ewa Ellis, Joanne Walsh, Anna Renblom, Lisa Fredriksson Puigvert, Anita C. A. Dankers, Frank Jacobs, Jan Snoeys, Rowena L. Sison-Young, Rosalind E. Jenkins, Åsa Nordling, Souren Mkrtchian, B. Kevin Park, Neil R. Kitteringham, Christopher E. P. Goldring, Volker M. Lauschke & Magnus Ingelman-Sundberg. (2016) Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Scientific Reports 6:1.
Crossref
Crossref
Eric A. G. Blomme & Yvonne Will. (2015) Toxicology Strategies for Drug Discovery: Present and Future. Chemical Research in Toxicology 29:4, pages 473-504.
Crossref
Crossref
Lizhen Huang, Shuxiang Zou, Jifeng Deng, Tianming Dai, Jingwei Jiang, Ying Jia, Renke Dai & Shuilin Xie. (2016) Development of an optimized cytotoxicity assay system for CYP3A4-mediated metabolic activation via modified piggyBac transposition. Toxicology in Vitro 32, pages 132-137.
Crossref
Crossref
Wei SUN, Yu-Qing CHEN, Guo-An LUO, Min ZHANG, Hong-Yang ZHANG, Yue-Rong WANG & Ping HU. (2016) Organs-on-chips and Its Applications. Chinese Journal of Analytical Chemistry 44:4, pages 533-541.
Crossref
Crossref
Natalie Herzog, Max Hansen, Sebastian Miethbauer, Kai-Uwe Schmidtke, Ursula Anderer, Amelie Lupp, Sebastian Sperling, Daniel Seehofer, Georg Damm, Katrin Scheibner & Jan-Heiner K?pper. (2016) Primary-like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures. Cell Biology International 40:3, pages 341-353.
Crossref
Crossref
M. Schaefer, G. Schanzle, D. Bischoff & R. D. Sussmuth. (2015) Upcyte Human Hepatocytes: a Potent In Vitro Tool for the Prediction of Hepatic Clearance of Metabolically Stable Compounds. Drug Metabolism and Disposition 44:3, pages 435-444.
Crossref
Crossref
Hyun-Sik Nam, Kyu-Seok Hwang, Yun-Mi Jeong, Jeong-Im Ryu, Tae-Young Choi, Myung-Ae Bae, Woo-Chan Son, Kwan-Hee You, Hwa-Young Son & Cheol-Hee Kim. (2016) Expression of miRNA-122 Induced by Liver Toxicants in Zebrafish. BioMed Research International 2016, pages 1-7.
Crossref
Crossref
Harriet Gaskell, Parveen Sharma, Helen E. Colley, Craig Murdoch, Dominic P. Williams & Steven D. Webb. (2016) Characterization of a functional C3A liver spheroid model. Toxicology Research 5:4, pages 1053-1065.
Crossref
Crossref
Leonard J. Nelson, Maria Navarro, Philipp Treskes, Kay Samuel, Olga Tura-Ceide, Steven D. Morley, Peter C. Hayes & John N. Plevris. (2015) Acetaminophen cytotoxicity is ameliorated in a human liver organotypic co-culture model. Scientific Reports 5:1.
Crossref
Crossref
Fozia Noor. (2015) A shift in paradigm towards human biology-based systems for cholestatic-liver diseases. The Journal of Physiology 593:23, pages 5043-5055.
Crossref
Crossref
Seigo Sanoh. (2015) <i>In Vitro</i> and <i>in Vivo</i> Assessments of Drug-induced Hepatotoxicity and Drug Metabolism in Humansヒトにおける医薬品の肝毒性及び代謝物の <i>in vitro</i>, <i>in vivo</i> 予測評価系の構築に関する研究. YAKUGAKU ZASSHI 135:11, pages 1273-1279.
Crossref
Crossref
Takafumi Tomida, Hayao Okamura, Masahiro Satsukawa, Tsuyoshi Yokoi & Yoshihiro Konno. (2015) Multiparametric assay using HepaRG cells for predicting drug-induced liver injury. Toxicology Letters 236:1, pages 16-24.
Crossref
Crossref
Emanuel Raschi. (2015) Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk. World Journal of Hepatology 7:13, pages 1761.
Crossref
Crossref
Yasuyuki Naito, Yuka Yoshinouchi, Yukiko Sorayama, Hiroshi Kohara, Shiro Kitano, Shinji Irie & Michiya Matsusaki. (2021) Constructing Vascularized Hepatic Tissue by Cell Assembled Viscous Tissue Sedimentation Method and Its Application for Vascular Toxicity Assessment. SSRN Electronic Journal.
Crossref
Crossref